To identify novel potent HDAC6 inhibitors against ovarian cancer, the anticancer activity of 46 potential HDAC6 inhibitors was evaluated using the MTT assay in ES-2 ovarian cancer cells. The gene discussed is HDAC6; the disease is ovarian carcinoma.